Evolus, Inc. (EOLS)
7.14
-0.55
(-7.15%)
USD |
NASDAQ |
Oct 02, 16:00
7.135
0.00 (0.00%)
After-Hours: 20:00
Evolus Price : 7.14 for Oct. 2, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 02, 2026 | 7.72 | 7.72 | 6.913 | 7.14 | 2.071M |
| Oct 01, 2026 | 7.89 | 8.01 | 7.69 | 7.69 | 922569.0 |
| Sep 30, 2026 | 7.97 | 8.15 | 7.87 | 8.00 | 624366.0 |
| Sep 29, 2026 | 7.91 | 8.11 | 7.83 | 7.99 | 415054.0 |
| Sep 28, 2026 | 7.90 | 8.075 | 7.805 | 7.96 | 478232.0 |
| Sep 25, 2026 | 7.84 | 8.00 | 7.712 | 7.97 | 398312.0 |
| Sep 24, 2026 | 7.96 | 8.00 | 7.79 | 7.86 | 362958.0 |
| Sep 23, 2026 | 8.33 | 8.51 | 7.88 | 8.00 | 415976.0 |
| Sep 22, 2026 | 8.10 | 8.265 | 8.00 | 8.25 | 500740.0 |
| Sep 21, 2026 | 7.93 | 7.995 | 7.76 | 7.99 | 420740.0 |
| Sep 18, 2026 | 8.00 | 8.00 | 7.805 | 7.86 | 1.182M |
| Sep 17, 2026 | 8.05 | 8.14 | 7.77 | 8.01 | 1.225M |
| Sep 16, 2026 | 7.93 | 8.09 | 7.82 | 7.99 | 683412.0 |
| Sep 15, 2026 | 7.88 | 7.95 | 7.59 | 7.91 | 637971.0 |
| Sep 14, 2026 | 7.90 | 8.25 | 7.87 | 7.93 | 515644.0 |
| Sep 11, 2026 | 8.01 | 8.150 | 7.81 | 7.84 | 586592.0 |
| Sep 10, 2026 | 8.43 | 8.450 | 7.75 | 7.91 | 1.212M |
| Sep 09, 2026 | 8.85 | 9.05 | 8.51 | 8.57 | 996576.0 |
| Sep 08, 2026 | 9.00 | 9.12 | 8.751 | 8.88 | 1.728M |
| Sep 04, 2026 | 9.05 | 9.31 | 8.975 | 9.30 | 696365.0 |
| Sep 03, 2026 | 9.08 | 9.10 | 8.91 | 9.05 | 734417.0 |
| Sep 02, 2026 | 9.04 | 9.13 | 8.93 | 9.06 | 773979.0 |
| Sep 01, 2026 | 9.04 | 9.124 | 8.93 | 9.08 | 594023.0 |
| Aug 31, 2026 | 8.85 | 9.15 | 8.75 | 9.09 | 1.027M |
| Aug 28, 2026 | 8.84 | 8.94 | 8.595 | 8.88 | 1.059M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ANI Pharmaceuticals, Inc. | 72.18 |
| Corcept Therapeutics, Inc. | 116.23 |
| Veru, Inc. | 2.51 |
| Johnson & Johnson | 256.03 |
| Eli Lilly & Co. | 1142.85 |
Price Related Metrics
| PS Ratio | 1.473 |
| Earnings Yield | -7.38% |
| Market Cap | 471.34M |